Cell‐Free and Concentrated Ascites Reinfusion Therapy ( <scp>CART</scp> ) Shows Enhanced Efficacy in Gynecological Cancer Patients: A Post‐Marketing Surveillance Study
CART demonstrates enhanced efficacy in gynecological cancer patients, particularly improving renal function, potentially reducing chemotherapy-related toxicity, and improving treatment tolerability.
Authors
- Go Murayama
- Junna Terao
- Yasuhisa Terao (ORCID: https://orcid.org/0000-0002-9126-3361)
- Nami Tamura (ORCID: https://orcid.org/0009-0001-4235-6780)
- Noriko Soneda
- Makio Kusaoi (ORCID: https://orcid.org/0000-0003-0064-4765)
- Emiko Yoshida (ORCID: https://orcid.org/0000-0002-8249-490X)
- Naoko Torii
- Kengo Hiranuma (ORCID: https://orcid.org/0000-0001-8197-4031)
- Takashi Hirayama (ORCID: https://orcid.org/0000-0001-5993-6688)
- Toshiyuki Okumura
- Ken Yamaji (ORCID: https://orcid.org/0000-0002-0565-1828)
- Misato Kawata
- Kazunari Fujino
Institutions
- Juntendo University (JP)
- Asahi Kasei (Japan) (JP)
Publication Details
- Journal
- Therapeutic Apheresis and Dialysis
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1111/1744-9987.70077
- Citations
- 1
- Primary Topic
- Dialysis and Renal Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 1.43